Mifepristone as a late post-coital contraceptive

被引:28
作者
Ashok, PW
Wagaarachchi, PT
Flett, GM
Templeton, A
机构
[1] Univ Aberdeen, Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Aberdeen AB25 2ZL, Scotland
[2] Grampian Healthcare NHS Trust, Family Planning Clin, Aberdeen AB10 1RH, Scotland
关键词
emergency or post-coital contraception; IUCD; mifepristone;
D O I
10.1093/humrep/16.1.72
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study was undertaken to assess the efficacy of mifepristone as a post-coital contraceptive beyond 72 h and up to 5 days in women who found the intrauterine contraceptive device (IUCD) unacceptable, During a 2 year period 219 consecutive women fulfilling the inclusion criteria and presenting late for emergency contraception were approached and offered a choice of methods. Fifteen (6.8%) women wished to have the IUCD fitted, but 204 (93.2%) who found this unacceptable were offered and accepted mifepristone 200 mg, In one woman there was a technical problem fitting the IUCD and mifepristone was administered. Women who had mifepristone were younger (mean age 21.4 versus 26.9 years, P = 0.004) and more likely to be nulliparous (81 versus 25 %, P < 0.001) than the IUCD group. A total of 155 (75.6%) women who had mifepristone and all 14 who had the coil fitted were followed up. There were no true failures in either group. There was one user failure in the mifepristone group, where pregnancy occurred from an act of intercourse subsequent to treatment, giving a crude pregnancy rate of 0.65%, Mifepristone prevented 85% of expected pregnancies. Most women find the IUCD an unacceptable method of post-coital contraception. Mifepristone is an effective late post-coital contraceptive, which can be offered to women who decline the IUCD.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 20 条
[1]  
BAIRD DT, 1993, NEW ENGL J MED, V328, P1543
[2]   MIFEPRISTONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
BROGDEN, RN ;
GOA, KL ;
FAULDS, D .
DRUGS, 1993, 45 (03) :384-409
[3]  
ESCHENBACH DA, 1992, FERTIL STERIL, V57, P1177
[4]  
*EXP ADV GROUP, 1998, CHLAM TRACH SUMM CON, P1
[5]   INTRAUTERINE-DEVICES AND PELVIC INFLAMMATORY DISEASE - AN INTERNATIONAL PERSPECTIVE [J].
FARLEY, TMM ;
ROSENBERG, MJ ;
ROWE, PJ ;
CHEN, JH ;
MEIRIK, O .
LANCET, 1992, 339 (8796) :785-788
[6]   EFFECTS OF A SINGLE POSTOVULATORY DOSE OF RU486 ON ENDOMETRIAL MATURATION IN THE IMPLANTATION PHASE [J].
GEMZELLDANIELSSON, K ;
SVALANDER, P ;
SWAHN, ML ;
JOHANNISSON, E ;
BYGDEMAN, M .
HUMAN REPRODUCTION, 1994, 9 (12) :2398-2404
[7]   EARLY LUTEAL-PHASE TREATMENT WITH MIFEPRISTONE (RU-486) FOR FERTILITY REGULATION [J].
GEMZELLDANIELSSON, K ;
SWAHN, ML ;
SVALANDER, P ;
BYGDEMAN, M .
HUMAN REPRODUCTION, 1993, 8 (06) :870-873
[8]   MIFEPRISTONE (RU-486) COMPARED WITH HIGH-DOSE ESTROGEN AND PROGESTOGEN FOR EMERGENCY POSTCOITAL CONTRACEPTION [J].
GLASIER, A ;
THONG, KJ ;
DEWAR, M ;
MACKIE, M ;
BAIRD, DT .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15) :1041-1044
[9]  
Grimes D, 1998, LANCET, V352, P428
[10]   INHIBITION OF OVULATION BY LOW-DOSE MIFEPRISTONE (RU-486) [J].
LEDGER, WL ;
SWEETING, VM ;
HILLIER, H ;
BAIRD, DT .
HUMAN REPRODUCTION, 1992, 7 (07) :945-950